id: NEW:nafld_related_hcc_to_NEW:cirrhosis_prevalence_hcc_patients
name: NAFLD-Related Hepatocellular Carcinoma â†’ Cirrhosis Prevalence in HCC Patients
from_node:
  node_id: NEW:nafld_related_hcc
  node_name: NAFLD-Related Hepatocellular Carcinoma
to_node:
  node_id: NEW:cirrhosis_prevalence_hcc_patients
  node_name: Cirrhosis Prevalence in HCC Patients
direction: negative
category: biological
mechanism_pathway:
- 'Step 1: NAFLD-related HCC can develop through non-cirrhotic pathways, where hepatocarcinogenesis
  occurs via direct lipotoxicity, oxidative stress, and chronic inflammation in steatotic
  liver tissue without requiring progression to cirrhosis'
- 'Step 2: Metabolic dysfunction in NAFLD (insulin resistance, lipid accumulation,
  adipokine dysregulation) creates a pro-oncogenic environment that promotes hepatocyte
  transformation independent of the fibrosis-cirrhosis-cancer sequence typical of
  viral hepatitis or alcohol-related liver disease'
- 'Step 3: As a result, patients with NAFLD-related HCC have significantly lower prevalence
  of underlying cirrhosis (50.4%) compared to patients with HCC from other etiologies
  (64.0%), demonstrating NAFLD''s unique carcinogenic pathway'
evidence:
  quality_rating: A
  n_studies: 17
  primary_citation: 'Jiaoling Su et al. 2023. "Prognosis after hepatic resection of
    patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease:
    meta-analysis." BJS Open.'
  supporting_citations: []
description: Meta-analysis of 17 studies (11,477 patients) demonstrates that NAFLD-related
  HCC is associated with significantly lower cirrhosis prevalence (50.4% vs 64.0%,
  P<0.001) compared to HCC of other etiologies. This reflects NAFLD's unique pathophysiology
  where hepatocellular carcinoma can develop through metabolic and lipotoxic pathways
  without requiring progression through cirrhosis, unlike viral or alcohol-related
  liver disease.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
moderators:
- name: geographic_region
  direction: strengthens
  strength: moderate
  description: Asian populations showed more pronounced survival benefits for NAFLD-related
    HCC patients, possibly related to lower cirrhosis rates and different metabolic
    profiles
- name: body_mass_index
  direction: strengthens
  strength: moderate
  description: NAFLD-related HCC patients had higher BMI, reflecting the metabolic
    syndrome etiology that enables non-cirrhotic hepatocarcinogenesis
- name: age
  direction: strengthens
  strength: weak
  description: NAFLD-related HCC patients were older, suggesting longer exposure to
    metabolic risk factors may compensate for lack of cirrhosis in cancer development
